2022年度このページを印刷する - 2022年度

2025年1月8日掲載

2022年度
英文論文
  1. Yamaguchi T, Matsunuma R, Matsuda Y, Tasaki J, Ikari T, Miwa S, Aiki S, Takagi Y, Kiuchi D, Suzuki K, Oyamada S, Ariyoshi K, Kihara K, Mori M. Systemic Opioids for Dyspnea in Cancer Patients: A Real-world Observational Study. Journal of Pain and Symptom Management. 2023 May;65(5):400-408.(松田能宣)
 
  1. Tanizaki S, Matsumoto K, Tamiya A, Taniguchi Y, Matsuda Y, Uchida J, Ueno K, Kawachi H, Tamiya M, Yanase T, Suzuki H, Okishio K. Sequencing strategies with ramucirumab and docetaxel following prior treatments for advanced non-small cell lung cancer: a multicenter retrospective cohort study. European Journal of Clinical Microbiology & Infectious Diseases. 2023 Apr;503-511.(田宮朗裕)
 
  1. Yasuda S,Sugano K,Matsuda Y,Kako J,Takagi Y,Watanabe H,Kasahara Y,Goya S,Kohara H,Mori M,Nakayama T,Yamaguchi T. Systematic review and meta-analysis of the efficacy of benzodiazepines for dyspnea in patients with cancer. Japanese Journal of Clinical Oncology. 2023 MAR 30;53(4):327-334.(松田能宣)
 
  1. Fujisawa T,Akiyama N,Morita T,Koyauchi T,Matsuda Y,Mori M,Miyashita M,Tachikawa R,Tomii K,Tomioka H,Hagimoto S,Kondoh Y,Inoue Y,Suda T. Palliative care for interstitial lung disease: A nationwide survey of pulmonary specialists. Respirology. 2023 MAR 22;(松田能宣)
 
  1. Kurahara Y,Shimatani Y. Melanoptysis. Qjm: an International Journal of Medicine. 2023 MAR 21;(倉原優)
 
  1. Taniguchi Y,Tamiya A,Yanagisawa A,Shimaya M,Kawakami M,Inagaki Y,Saijo N,Matsuda Y,Okishio K. Cerebral infarction after treatment with dabrafenib plus trametinib for BRAF-V600E-positive non-small cell lung cancer: A case report. Thoracic Cancer. 2023 MAR 19;(谷口善彦)
 
  1. Mori M,Yamaguchi T,Suzuki K,Matsuda Y,Matsunuma R,Watanabe H,Ikari T,Matsumoto Y,Imai K,Yokomichi N,Miwa S,Yamauchi T,Okamoto S,Inoue S,Inoue A,Morita T,Satomi E,Japanese Dyspnea Relief Investigat. The feasibility and effects of a pharmacological treatment algorithm for cancer patients with terminal dyspnea: A multicenter cohort study. Cancer Medicine. 2023 MAR;12(5):5397-5408.(松田能宣)
 
  1. Tani Y,Kaneda H,Koh Y,Tamiya A,Isa S,Kubo A,Ogawa K,Matsumoto Y,Sawa K,Yoshimoto N,Mitsuoka S,Kawaguchi T. The Impact of Estrogen Receptor Expression on Mutational Status in the Evolution of Non-Small Cell Lung Cancer. Clinical Lung Cancer. 2023 MAR;24(2):165-174.(伊佐俊一)
 
  1. Kagawa T, Nagano H, Iwasaku M, Kawano R, Hirayama Y, Uraguchi K, Yoshioka T. Gastroesophageal Reflux Disease or Proton Pump Inhibitor Use?: A Controversy Over the Association of Nontuberculous Mycobacterial Pulmonary Disease. Chest. 2023 Mar;163(3):e147-e148.(香川智子)
 
  1. Fujimoto D, Miura S, Tomii K, Sumikawa H, Yoshimura K, Wakuda K, Oya Y, Yokoyama T, Kijima T, Asao T, Tamiya M, Nakamura A, Yoshioka H, Tokito T, Murakami S, Tamiya A, Yokouchi H, Watanabe S, Yamaguchi O, Morinaga R, Jodai T, Ito K, Shiraishi Y, Kogure Y, Shibaki R, Yamamoto N. Pneumonitis associated with pembrolizumab plus chemotherapy for non-squamous non-small cell lung cancer. Sci Rep. 2023 Mar;13(1):3698.(澄川裕充)
 
  1. Akihiro Tamiya, Motohiro Tamiya, Yuji Inagaki, Yoshihiko Taniguchi, Keiko Nakao, Yoshinobu Matsuda, Takahisa Kawamura, Kei Kunimasa, Takako Inoue, Kazumi Nishino, Kyoichi Okishio. Bevacizumab Plus Carboplatin Plus Nab-paclitaxel for Non-squamous Non-small Cell Lung Cancer in a Real-world Setting. Anticancer Research. 2023 Mar;43(3):1325-1330.(田宮朗裕)
 
  1. Abe A, Fujisawa D, Miyajima K, Takeuchi E, Takeuchi M, Mimura M, Imai K, Uemura K, Watanabe H, Matsuo N, Matsuda Y, Maeda I, Ogawa A, Yoshiuchi K, Iwase S. Influence of dosing pattern of antipsychotics on treatment outcome of delirium in patients with advanced cancer. Japanese Journal of Clinical Oncology. 2023 Mar;53(4):321-326.(松田能宣)
 
  1. Toru Arai, Masaki Hirose, Tomoko Kagawa, Kazuyoshi Hatsuda, Yoshikazu Inoue. Interleukin-11 in idiopathic pulmonary fibrosis: predictive value of prognosis and acute exacerbation. Journal of Thoracic Disease. 2023 Feb;15(2):300-310.(新井徹)
 
  1. Takeuchi S,Kubota K,Sugawara S,Teramukai S,Noro R,Fujikawa K,Hirose T,Atagi S,Minami S,Iida S,Kuraishi H,Aiba T,Minegishi Y,Matsumoto M,Seike M,Gemma A,Kawahara M,Japan-Multinational Trial Org JMTO. Standard versus low-dose nab-paclitaxel in previously treated patients with advanced non-small cell lung cancer: A randomized phase II trial (JMTO LC14-01). Cancer Medicine. 2023 FEB 21;(安宅信二)
 
  1. Kurahara Y, Nagayama I. Bilothorax. New England Journal of Medicine. 2023 Feb;388(7):e17.(倉原優)
 
  1. Hamamoto Y,Kawamura M,Uchida H,Takagahara K,Katori C,Asai H,Harada H,Shimizu S,Morii E,Yoshida K. Aberrant MUC Immunohistochemical Expressions in Inflammatory Bowel Diseases. Applied Immunohistochemistry & Molecular Morphology. 2023 FEB;31(2):107-112.(清水重喜)
 
  1. Ogura T,Inoue Y,Azuma A,Homma S,Kondoh Y,Tanaka K,Ochiai K,Sugiyama Y,Nukiwa T. Real-World Safety and Tolerability of Nintedanib in Patients with Idiopathic Pulmonary Fibrosis: Interim Report of a Post-Marketing Surveillance in Japan. Advances in therapy. 2023 JAN 24;(井上義一)
 
  1. Osaki M,Arai T,Sumikawa H,Takimoto T,Takeuchi N,Tamiya A,Okishio K,Inoue Y. Immune Checkpoint Inhibitor-Related Pneumonitis in Lung Cancer Patients with Interstitial Lung Disease: Significance of Radiological Pleuroparenchymal Fibroelastosis. Oncology. 2023 JAN 23;(大﨑恵)
 
  1. Imai K, Morita T, Mori M, Kiuchi D, Yokomichi N, Miwa S, Okamoto S, Yamauchi T, Naito AS, Matsuda Y, Maeda I, Sugano K, Ikenaga M, Inoue S, Satomi E. Visualizing How to Use Antipsychotics for Agitated Delirium in the Last Days of Life. Journal of Pain and Symptom Management. 2023 Jan;(松田能宣)
 
  1. K. Kojima;H Yoon; K. Okishio; K. Tsuyuguchi. Increased lactate dehydrogenase reflects the progression of COVID-19 pneumonia on chest computed tomography and predicts subsequent severe disease. Scientific Reports. 2023 1;131012.(小島健介)
 
  1. Suzukawa M, Ohta K, Hashimoto H, Oyamada Y, Miki M, Ogawara M, Inoue Y, Saito AM, Fukutomi Y, Kobayashi N, Taniguchi M, NHOM- Asthma Study Group. Characterization and cluster analyses of elderly asthma in comparison with non-elderly asthma patients in Japan. ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY. doi: 10.1016/j.anai.2023.01.003.(井上義一)
 
  1. Inoue Y,Wells AU,Song JW,Xu ZJ,Kitamura H,Suda T,Okamoto M,Muller H,Coeck C,Rohr KB,Kolb M,Brown KK. Nintedanib in Asian patients with progressive fibrosing interstitial lung diseases: Results from the INBUILD trial. Respirology. 2023 JAN 15;(井上義一)
 
  1. Moda M,Arai T,Takeuchi N,Kagawa T,Takimoto T,Sumikawa H,Shimizu S,Inoue Y. Fibrotic Hypersensitivity Pneumonitis Diagnosed by a Re-evaluation with Bronchoalveolar Lavage at Disease Deterioration. Internal Medicine. 2023;62(4):577-582.(茂田光弘)
 
  1. Okuda R,Ogura T,Hisata S,Baba T,Kondoh Y,Suda T,Johkoh T,Iwasawa T,Tomioka H,Bando M,Azuma A,Inoue Y,Arai T,Nakamura Y,Miyamoto A,Miyazaki Y,Chiba H,Ishii H,Hamada N,Terasaki Y,Kuwahira I,Sato S,Kato S,Suzuki T,Sakamoto S,Nishioka Y,Hattori N,Hashimoto N,Morita S,Ichihara N,Miyata H,Hagiwara K,Nukiwa T,Kobayashi K. Design and rationale of the Japanese Idiopathic Interstitial Pneumonias (JIPS) Registry. Respiratory Investigation. 2023 JAN;61(1):95-102.(井上義一)
 
  1. Imaji M, Fujimoto D, Sato Y, Sakata Y, Oya Y, Tamiya M, Suzuki H, Ikeda H, Kijima T, Matsumoto H, Kanazu M, Hino A, Inaba M, Tsukita Y, Arai D, Maruyama H, Hara S, Tsumura S, Kobe H, Sumikawa H, Sakata S, Yamamoto N. Safety and efficacy of osimertinib rechallenge or continuation after pneumonitis: A multicentre retrospective cohort study. Eur J Cancer. 2023 Jan;17915-24.(澄川裕充)
 
  1. Suzukawa M, Ohta K, Fukutomi Y, Hashimoto H, Endo T, Abe M, Kamide Y, Yoshida M, Kikuchi Y, Kita T, Chibana K, Tanimoto Y, Hyodo K, Takata S, Inui T, Yasui M, Harada Y, Sato T, Sakakibara Y, Minakata Y, Inoue Y, Tamaki S, Shinohara T, Takami K, Tsubakihara M, Oki M, Wakamatsu K, Horiba M, Ideura G, Hidaka K, Saito AM, Kobayashi N, Taniguchi M. Classifications of moderate to severe asthma phenotypes in Japan and analysis of serum biomarkers: A Nationwide Cohort Study in Japan (NHOM Asthma Study). Allergology International. 2023 Jan;72(1):63-74.(井上義一)
 
  1. Hiroyuki Otani, Amano K, Morita T, Miura T, Mori N, Tatara R, Kessoku T, Matsuda Y, Tagami K, Mori M, Taniyama T, Nakajima N, Nakanishi E, Kako J, Shirado AN, Yokomichi N, Miyashita M. Impact of taste/smell disturbances on dietary intakes and cachexia-related quality of life in patients with advanced cancer. Support Care Cancer. 2023 Jan;31(2):141.(松田能宣)
 
  1. Oda M, YamauramK, Ishii H, Kitamura N, Tazawa R, Abe M, Tatsumi K, Eda R, Kondoh S, Morimoto K, Tanaka T, Yamaguchi E, Takahashi A, Izumi S, Sugiyama H, Nakagawa A, Tomii K, Suzuki M, Konno S, Ohkouchi S, Tode N, Handa T, Hirai T, Inoue Y, Arai T, Asakawa K, Tanaka T, Takada T, Nonaka H, Nakata K. Quantitative Evaluation of Changes in Three-Dimensional CT Density Distributions in Pulmonary Alveolar Proteinosis after GM-CSF Inhalation. Respiration. 2023;102(2):101-109.(井上義一)
 
  1. Moda M,Suga M,Kasai S,Okochi Y,Yoshimura N,Fukata M,Tokuda H. Incidence, Characteristics, Clinical Course, and Risk Factors of Ulcerative Colitis-related Lung Diseases. Chest. 2022 DEC;162(6):1310-1323.(茂田光弘)
 
  1. Nagata K,Horie T,Chohnabayashi N,Jinta T,Tsugitomi R,Shiraki A,Tokioka F,Kadowaki T,Watanabe A,Fukui M,Kitajima T,Sato S,Tsuda T,Kishimoto N,Kita H,Mori Y,Nakayama M,Takahashi K,Tsuboi T,Yoshida M,Hataji O,Fuke S,Kagajo M,Nishine H,Kobayashi H,Nakamura H,Okuda M,Tachibana S,Takata S,Osoreda H,Minami K,Nishimura T,Ishida T,Terada J,Takeuchi N,Kohashi Y,Inoue H,Nakagawa Y,Kikuchi T,Tomii K,FLOCOP Study Investigators. Home High-Flow Nasal Cannula Oxygen Therapy for Stable Hypercapnic COPD. American Journal of Respiratory and Critical Care Medicine. 2022 DEC 1;206(11):1326-1335.(竹内奈緒子)
 
  1. Takeuchi N,Arai T,Sasaki Y,Akira M,Matsuda Y,Tachibana K,Kasai T,Inoue Y. Predictive factors for relapse in corticosteroid-treated patients with chronic eosinophilic pneumonia. Journal of Thoracic Disease. 2022 NOV 29;14(11):4352-4360.(竹内奈緒子)
 
  1. Amano K,Morita T,Miura T,Mori N,Tatara R,Kessoku T,Matsuda Y,Tagami K,Otani H,Mori M,Taniyama T,Nakajima N,Nakanishi E,Kako J,Ishiki H,Matsuoka H,Satomi E,Hopkinson JB,Baracos VE,Miyashita M. Development and validation of questionnaires for eating-related distress among advanced cancer patients and families. Journal of Cachexia、Sarcopenia and Muscle. 2022 NOV 20;(松田能宣)
 
  1. Taniguchi Y,Matsuda Y,Mori M,Ito M,Ikari T,Tokoro A,Aiki S,Hoshino S,Kiuchi D,Suzuki K,Igarashi Y,Odagiri T,Oya K,Kubo E,Yamaguchi T. Effectiveness and safety of opioids for dyspnea in patients with lung cancer: secondary analysis of multicenter prospective observational study. Translational Lung Cancer Research. 2022 NOV 12;(谷口善彦)
 
  1. Sato K,Akamatsu H,Koh Y,Ogawa K,Isa SI,Ando M,Tamiya A,Kubo A,Kitagawa C,Kawaguchi T,Yamamoto N. Differential properties of KRAS transversion and transition mutations in non-small cell lung cancer: associations with environmental factors and clinical outcomes. BMC Cancer. 2022 NOV 8;22(1):(伊佐俊一)
 
  1. Hasegawa T,Okuyama T,Uemura T,Matsuda Y,Otani H,Shimizu J,Horio Y,Watanabe N,Yamaguchi T,Fukuda S,Oguri T,Maeno K,Tamiya A,Nosaki K,Fukumitsu K,Akechi T. Prognostic Awareness and Discussions of Incurability in Patients with Pretreated Non-Small Cell Lung Cancer and Caregivers: A Prospective Cohort Study. Oncologist. 2022 NOV 3;27(11):982-990.(松田能宣)
 
  1. Sato Y,Sumikawa H,Shibaki R,Morimoto T,Sakata Y,Oya Y,Tamiya M,Suzuki H,Matsumoto H,Yokoi T,Hashimoto K,Kobe H,Hino A,Inaba M,Tsukita Y,Ikeda H,Arai D,Maruyama H,Hara S,Tsumura S,Sakata S,Fujimoto D. Drug-Related Pneumonitis Induced by Osimertinib as First-Line Treatment for Epidermal Growth Factor Receptor Mutation-Positive Non-Small Cell Lung Cancer A Real-World Setting. Chest. 2022 NOV;162(5):1188-1198.(澄川裕充)
 
  1. Yoshida S,Tsuyuguchi K,Kobayashi T,Shimatani Y,Inoue Y. Effect of sputum quality on Mycobacterium avium-intracellulare complex lung disease diagnosis and treatment initiation according to disease type. Diagnostic Microbiology and Infectious Disease. 2022 NOV;104(3):(吉田志緒美)
 
  1. Ogura T,Suda T,Inase N,Nishioka Y,Azuma A,Okamoto M,Takizawa A,Ito T,Rohr KB,Inoue Y. Effects of nintedanib on disease progression and safety in Japanese patients with progressive fibrosing interstitial lung diseases: Further subset analysis from the whole INBUILD trial. Respiratory Investigation. 2022 NOV;60(6):787-797.(井上義一)
 
  1. Yamada A,Kagawa T,Nishimoto Y,Sugawara R,Arai T,Inoue Y,Taiji R,Okada H,Takewa M,Sugimura H,Tanaka T. Exogenous Lipoid Pneumonia Caused by Gargling With Sesame Oil A Case Report. Journal of Thoracic Imaging. 2022 NOV;37(6):W97-W100.(香川智子)
 
  1. Akiyama N,Fujisawa T,Morita T,Koyauchi T,Matsuda Y,Mori M,Miyashita M,Tachikawa R,Tomii K,Tomioka H,Hagimoto S,Kondoh Y,Inoue Y,Suda T. End-of-life care for idiopathic pulmonary fibrosis patients with acute exacerbation. Respiratory Research. 2022 OCT 29;23(1):(松田能宣)
 
  1. Takimoto T. Corticosteroids for pulmonary lymphangitic carcinomatosis. BMJ Supportive and Palliative Care. 2022 OCT 27;(滝本宜之)
 
  1. Kojima K,Imai S,Samejima H,Fujiwara A,Tokunaga T,Yoon H,Okishio K. PIK3CA mutations associated with a poor postoperative prognosis in patients with pulmonary pleomorphic carcinoma: a retrospective cohort study. BMC Cancer. 2022 OCT 15;22(1):(小島健介)
 
  1. Sa-ngiamwibool P,Hamasaki M,Kinoshita Y,Matsumoto S,Sato A,Tsujimura T,Kasai T,Hiroshima K,Kushitani K,Takeshima Y,Kawahara K,Iwasaki A,Nabeshima K. Challenges and limitation of MTAP immunohistochemistry in diagnosing desmoplastic mesothelioma/sarcomatoid pleural mesothelioma with desmoplastic features. Annals of Diagnostic Pathology. 2022 OCT;60(笠井孝彦)
 
  1. Kurahara Y, Matsuda Y, Tsuyuguchi K, Tokoro A. Delirium in Patients with COVID-19 in Japan. Internal Medicine. 2022 Oct;61(19):2861-2866.(倉原優)
 
  1. Matsuda Y,Morita T,Oya K,Tagami K,Naito AS,Kashiwagi H,Otani H. Drug Choice for Hyperactive Delirium in Terminally-Ill Cancer Patients: A Nationwide Survey. Journal of Pain and Symptom Management. 2022 OCT;64(4):E231-E234.(松田能宣)
 
  1. Takimoto T, Kobayashi T, Minomo S. Concomitant Recurrent Pneumothorax and Takotsubo Cardiomyopathy in a Chronic Obstructive Pulmonary Disease Patient. Cureus Journal of Medical Science. 2022 Oct;14(10):e30850.(滝本宜之)
 
  1. Marinescu DC,Raghu G,Remy-Jardin M,Travis WD,Adegunsoye A,Beasley MB,Chung JH,Churg A,Cottin V,Egashira R,Perez ERF,Inoue Y,Johannson KA,Kazerooni EA,Khor YH,Lynch DA,Muller NL,Myers JL,Nicholson AG,Rajan S,Saito-Koyama R,Troy L,Walsh SLF,Wells AU,Wijsenbeek MS,Wright JL,Ryerson CJ. Integration and Application of Clinical Practice Guidelines for the Diagnosis of Idiopathic Pulmonary Fibrosis and Fibrotic Hypersensitivity Pneumonitis. Chest. 2022 SEP;162(3):614-629.(井上義一)
 
  1. Takimoto T,Nakamura Y. Serum Biomarkers in a Radiological Pattern of Non-Fibrotic Hypersensitivity Pneumonitis: Implications for Mechanistic Difference and Differential Diagnosis. Diseases. 2022 SEP;10(3):(滝本宜之)
 
  1. Tanaka M,Fujimoto D,Akamatsu H,Sumikawa H,Yamamoto N. Radiographic findings useful for diagnosis of primary chest wall lymphoma without preceding pleural disease: A case report. Respirology Case Reports. 2022 SEP;10(9):(澄川裕充)
 
  1. Nishioka Y,Toyoda Y,Egashira R,Johkoh T,Terasaki Y,Hebisawa A,Abe K,Baba T,Fujikura Y,Fujita E,Hamada N,Handa T,Hasegawa Y,Hidaka K,Hisada T,Hisata S,Honjo C,Ichikado K,Inoue Y,Izumi S,Kato M,Kishimoto T,Okamoto M,Miki K,Mineshita M,Nakamura Y,Sakamoto S,Sano M,Tsukada Y,Yamasue M,Bando Y,Homma S,Hagiwara K,Suda T,Inase N. Nationwide retrospective observational study of idiopathic dendriform pulmonary ossification: clinical features with a progressive phenotype. BMJ Open Respiratory Research. 2022 SEP;9(1):(井上義一)
 
  1. Kako J,Kobayashi M,Kanno Y,Kajiwara K,Nakano K,Morikawa M,Matsuda Y,Shimizu Y,Hori M,Niino M,Suzuki M,Shimazu T. Nursing support for symptoms in patients with cancer and caregiver burdens: a scoping review protocol. BMJ Open. 2022 SEP;12(9):(松田能宣)
 
  1. Kurahara Y. Fibrothorax in a Patient with Social Withdrawal. Internal Medicine. 2022;doi: 10.2169/internalmedicine.0333-22.(倉原優)
 
  1. Cottin V,Selman M,Inoue Y,Wong AW,Corte TJ,Flaherty KR,Han MK,Jacob J,Johannson KA,Kitaichi M,Lee JS,Agusti A,Antoniou KM,Bianchi P,Caro F,Florenzano M,Galvin L,Iwasawa T,Martinez FJ,Morgan RL,Myers JL,Nicholson AG,Occhipinti M,Poletti V,Salisbury ML,Sin DD,Sverzellati N,Tonia T,Valenzuela C,Ryerson CJ,Wells AU,Amer Thoracic Soc,European Resp Soc,Japanese Resp Soc,Assoc Latinoamer Torax. Syndrome of Combined Pulmonary Fibrosis and Emphysema An Official ATS/ERS/JRS/ALAT Research Statement. American Journal of Respiratory and Critical Care Medicine. 2022 AUG 15;206(4):E7-E41.(井上義一)
 
  1. Kurahara Y. Diabetic foot ulcer infection with Mycobacterium avium. Qjm: an International Journal of Medicine. 2022 AUG 13;115(8):540-540.(倉原優)
 
  1. Kurahara Y. Cryptococcal pericarditis. Qjm: an International Journal of Medicine. 2022 AUG 13;115(8):541-542.(倉原優)
 
  1. Matsuda Y,Morita T,Oya K,Tagami K,Naito AS,Kashiwagi H,Otani H. Current practice of pharmacological treatment for hyperactive delirium in terminally ill cancer patients: results of a nationwide survey of Japanese palliative care physicians and liaison psychiatrists. Japanese Journal of Clinical Oncology. 2022 AUG 5;52(8):897-902.(松田能宣)
 
  1. Abe A,Amano K,Morita T,Miura T,Mori N,Tatara R,Kessoku T,Matsuda Y,Tagami K,Otani H,Mori M,Taniyama T,Nakajima N,Nakanishi E,Kako J,Kiuchi D,Ishiki H,Matsuoka H,Satomi E,Miyashita M. Beliefs and Perceptions About Parenteral Nutrition and Hydration by Advanced Cancer Patients. Palliative Medicine Reports. 2022 AUG 1;3(1):132-139.(松田能宣)
 
  1. Oya K, Morita T, Tagami K, Matsuda Y, Naito AS, Kashiwagi H, Otani H. Physicians' Beliefs and Attitudes Toward Hypoactive Delirium in The Last Days of Life. Journal of Pain and Symptom Management. 2022 Aug;64(2):110-118.(松田能宣)
 
  1. Matsuda Y,Hasuo H,Narita K,Matsuoka H,Morita R,Kiuchi D,Ikari T,Hori T,Okazaki K,Sakai K,Aiki S,Okabayashi H,Oyamada S,Ariyoshi K,Tokoro A,Fukunaga M. Relationship between dyspnoea and related factors in patients with cancer: a cross-sectional study. BMJ Supportive and Palliative Care. 2022 JUL 19;(松田能宣)
 
  1. Matsumoto Y,Kawaguchi T,Watanabe M,Isa S,Ando M,Tamiya A,Kubo A,Kitagawa C,Yoshimoto N,Koh Y. Prognostic impact of pretreatment T790M mutation on outcomes for patients with resected, EGFR-mutated, non-small cell lung cancer. BMC Cancer. 2022 JUL 15;22(1):(伊佐俊一)
 
  1. Matsugi A,Nishishita S,Yoshida N,Tanaka H,Douchi S,Bando K,Tsujimoto K,Honda T,Kikuchi Y,Shimizu Y,Odagaki M,Nakano H,Okada Y,Mori N,Hosomi K,Saitoh Y. Impact of Repetitive Transcranial Magnetic Stimulation to the Cerebellum on Performance of a Ballistic Targeting Movement. Cerebellum. 2022 JUL 4;(堂地晋弥)
 
  1. Arai T,Inoue Y. Two cases of nintedanib-induced diarrhoea treated using a 5-hydroxytryptamine type 3 receptor antagonist. ERJ Open Research. 2022 JUL 1;8(3):(新井徹)
 
  1. Asami K,Ando M,Nishimura T,Yokoi T,Tamura A,Minato K,Mori M,Ogushi F,Yamamoto A,Yoshioka H,Kawahara M,Atagi S. A randomized phase II study of docetaxel or pemetrexed with or without the continuation of gefitinib after disease progression in elderly patients with non-small cell lung cancer harboring EGFR mutations (JMTO LC12-01). Thorac Cancer. 2022 JUN;13(12):1827-1836.(安宅信二)
 
  1. Tanaka-Yagi Y,Yamaguchi T,Matsuda Y,Mori M,Ikari T,Miwa S,Suzuki K,Tachikawa R,Nakata K,Kanatani M. Morphine May Contribute to Improving Respiratory Failure in Severe COVID-19: A Case Report. Indian Journal of Palliative Care. 2022 APR-JUN;28(2):221-223.(松田能宣)
 
  1. Raghu G,Remy-Jardin M,Richeldi L,Thomson CC,Inoue Y,Johkoh T,Kreuter M,Lynch DA,Maher TM,Martinez FJ,Molina-Molina M,Myers JL,Nicholson AG,Ryerson CJ,Strek ME,Troy LK,Wijsenbeek M,Mammen MJ,Hossain T,Bissell BD,Herman DD,Hon SM,Kheir F,Khor YH,Macrea M,Antoniou KM,Bouros D,Buendia-Roldan I,Caro F,Crestani B,Ho L,Morisset J,Olson AL,Podolanczuk A,Poletti V,Selman M,Ewing T,Jones S,Knight SL,Ghazipura M,Wilson KC,Amer Thoracic Soc,European Resp Soc,Japanese Resp Soc,Assoc Latinoamer Torax. Idiopathic Pulmonary Fibrosis (an Update) and Progressive Pulmonary Fibrosis in Adults An Official ATS/ERS/JRS/ALAT Clinical Practice Guideline. American Journal of Respiratory and Critical Care Medicine. 2022 MAY 1;205(9):E18-E47.(井上義一)
 
  1. Kurahara Y, Kobayashi T, Tachibana K, Tsuyuguchi K. The feasibility of rifampicin Re-administration in patients with tuberculosis and Clostridioides difficile infection. Journal of Infection and Chemotherapy. 2022 Apr;28(4):558-562.(倉原優)
 
  1. Kako J, Kobayashi M, Kajiwara K, Kimura Y, Oosono Y, Takegata M, Nakano K, Matsuda Y, Nakamura N, Kawashima N, Hirano Y, Kitae M, Yamaguchi K, Iwamoto H, Hattori N, Sawatari H, Shiono S, Ogino H, Nishioka Y, Amano K, Yorke J. Validity and Reliability of the Japanese Version of the Dyspnea-12 Questionnaire in Patients With Lung Cancer. Journal of Pain and Symptom Management. 2022 Aug;64(2):e83-e89.(松田能宣)
 
  1. Toru Arai, Masaki Hirose, Yoshimasa Hamano, Tomoko Kagawa, Akihiro Murakami, Hiroshi Kida, Atsushi Kumanogoh, Yoshikazu Inoue. Anti-Myxovirus Resistance Protein-1 Immunoglobulin A Autoantibody in Idiopathic Pulmonary Fibrosis. Canadian Respiratory Journal. 2022 Mar;22(新井徹)
 
  1. Corina N D'Alessandro-Gabazza, Taro Yasuma, Tetsu Kobayashi, Masaaki Toda, Ahmed M Abdel-Hamid, Hajime Fujimoto, Osamu Hataji, Hiroki Nakahara, Atsuro Takeshita, Kota Nishihama, Tomohito Okano, Haruko Saiki, Yuko Okano, Atsushi Tomaru, Valeria Fridman D'Alessandro, Miyako Shiraishi, Akira Mizoguchi, Ryoichi Ono, Junpei Ohtsuka, Masayuki Fukumura, Tetsuya Nosaka, Xuenan Mi, Diwakar Shukla, Kensuke Kataoka, Yasuhiro Kondoh, Masaki Hirose, Toru Arai, Yoshikazu Inoue, Yutaka Yano, Roderick I Mackie , Isaac Cann, Esteban C Gabazza. Inhibition of lung microbiota-derived proapoptotic peptides ameliorates acute exacerbation of pulmonary fibrosis. Nature Communication. 2022 Mar;13(1):1558-1580.(広瀬雅樹)
 
  1. Matsuda Y, Kosugi T, Yamanaka M, Fukumori T, Inoue A, Horiki M, Matsunuma R, Kataoka Y, Kitamura H, Kataoka K, Matsuoka H, Tokoro A, Inoue Y. Expectations of respiratory physicians from psychologists in palliative care for patients with non-cancer respiratory diseases. Respiratory Investigation. 2022 Mar;60(2):309-317.(松田能宣)
 
71. Toru Arai, Masaki Hirose, Tomoko Kagawa, Kazuyoshi Hatsuda, Yoshikazu Inoue. Platelet-derived growth factor can predict survival and acute exacerbation in patients with idiopathic pulmonary fibrosis. Journal of Thoracic Disease. 2022 Feb;14(2):78-294.(新井徹)
 
和文原著・著書等
1. 井上義一. リンパ脈管筋腫(LAM)症診療の手引き2022. リンパ脈管筋腫(LAM)症診療の手引き2022. 2023;
2. 井上義一. 8　リンパ脈管筋腫症. 呼吸器疾患最新の治療2023-2024. 2023;329-331.
3. 松田能宣. 各論　疾患別にみた実践！心療内科的診療術　2気管支喘息. そのとき心療内科医のならこう考える　かかりつけ医でもできる！心療内科的診療術. 2023;
4. 蓮尾英明, 松岡弘道, 松田能宣. がん患者の呼吸困難・痛み・精神症状を診るロジック−知っていればこんなに使える非薬物療法アプローチ！　薬物療法が本当に有効な病態を見抜く！※書籍. がん患者の呼吸困難・痛み・精神症状を診るロジック−知っていればこんなに使える非薬物療法アプローチ！　薬物療法が本当に有効な病態を見抜く！. 2023;
5. 倉原優. COVID-19と細菌性肺炎の合併. 治療. 2023;105306-11.
6. 滝本宜之. リンパ脈管筋腫症. 今日の治療指針. 2023;320-321.
7. 井上義一. リンパ脈管筋腫症. 最新ガイドラインに基づく呼吸器疾患診療指針2023-24. 2022;437-445.
8. 倉原優, 露口一成. 内視鏡下に声帯炎を観察しえたアミカシン硫酸塩吸入用製剤による失声の2例. Kekkaku. 2022;97(7):381-5.
9. 井上義一. 肺胞蛋白症（PAP). 間質性肺炎のみかた、考え方. 2022;127-134.
10. 井上義一. リンパ脈管筋腫症（LAM). 間質性肺炎のみかた、考え方. 2022;135-142.
11. 倉原優. 日常診療に潜む「処方カスケード」. 咳嗽. 総合診療. 2022;32(10):1205-1208.
12. 松田能宣. 【日常診療に潜む「処方カスケード」-その症状、薬のせいではないですか?】抑うつ　抗うつ薬を使う前に、こちらの薬をチェックせよ!(解説). 総合診療. 2022;32(10):1192-1195.
13. 倉原優, 東崇皓, 川﨑咲姫, 安井みのり, 岸本歩, 新谷亮多, 小林岳彦, 橘和延, 露口一成. アミカシン硫酸塩吸入用製剤（販売名アリケイス吸入液590mg）導入における医薬連携および調剤薬局へのアンケート調査. Kekkaku. 2022;97(6):353-60.
14. 井上義一. 特発性肺線維症の新規薬剤治験. 月刊雑誌　呼吸器内科. 2022;42339-343.
15. 岸本歩、赤井裕子、門野恵莉、中田華. 重症心身障害児・者病棟入院患者におけるポリファーマシーとその要因解析－長期服用漢方六君子湯の適正使用－. 漢方と最新治療. 2022;31(3):159-163.
16. 松田能宣. 【呼吸器疾患の緩和ケアを考える】非がん性呼吸器疾患の呼吸困難に対する薬物療法(解説). 呼吸器内科. 2022;42(2):142-145.
17. 吉田志緒美. 【医学細菌・真菌の分類と菌種の最新情報Up-to-Date ―注目すべき菌種を含めて】抗酸菌―近年,変更された菌種/新種を中心として. 臨床と微生物　49(4);333-341,2022. 2022;49(4):333-341.
18. 井上義一広瀬雅樹滝本宜之, 新井徹. リンパ脈管筋腫症. 日本臨床. 2022;80-増刊号6599-607.
19. 角甲純(兵庫県立大学看護学部), 中村陽一, 西智弘, 高木雄亮, 松田能宣, 渡邊紘章, 笠原庸子, 合屋将, 小原弘之, 森雅紀, 山口崇. 呼吸困難を有する慢性進行性疾患患者に対する送風療法の有効性　システマティックレビュー・メタ解析(原著論文). Palliative Care Research. 2022;17(1):33-42.
20. 倉原優. COPDと気管支喘息,その周辺疾患. 生物学的製剤TSLPモノクローナル抗体. 日本臨床増刊号・共著. 2022;468-472.
21. 倉原優. 総合診療外来に実装したい最新エビデンス My Best 3. 喘息. 総合診療. 2022;32(6):716-719.
22. 日本呼吸器学会肺胞蛋白症診療ガイドライン2022作成委員会. 肺胞蛋白症診療ガイドライン2022. 肺胞蛋白症診療ガイドライン2022. 2022;
23. 松田能宣. 【すっきりしない症状　まれな症状の緩和ケア-どこまでやったら合格か?】(第II章)すっきりしない呼吸器症状　パニック(不安発作)と同時にくる息苦しさ(解説). 緩和ケア. 2022;32(6月増刊):078-083.
24. 清水重喜、蓑毛祥次郎. 気管支拡張症. 非腫瘍性疾患病理アトラス. 2022;p198-203..
25. 清水重喜、前島亜希子、桂義久、杉野弘和、本間浩一、松野吉宏、河端美則. 寄生虫による肺病変. 非腫瘍性疾患病理アトラス. 2022;p361-366.
26. 清水重喜、岡元昌樹、富永正樹. コラム インジウム肺. 非腫瘍性疾患病理アトラス. 2022;p376..
27. 武田麻衣子、清水重喜、吉田恭太郎、大林千穂. 結核症および非結核性抗酸菌症. 非腫瘍性疾患病理アトラス. 2022;p316-323.
28. 清水重喜. リンパ性間質を伴う小結節性胸腺腫、化生性胸腺腫、脂肪線維腺腫、いわゆる顕微鏡的胸腺腫といわゆる硬化性胸腺腫. 腫瘍病理鑑別診断アトラス縦隔腫瘍・胸膜腫瘍第二版. 2022;P31-39.
29. 清水重喜. 胸膜生検、細胞診セルブロック. 腫瘍病理鑑別診断アトラス縦隔腫瘍・胸膜腫瘍第二版. 2022;P197-205.
30. 冨岡洋海, 宮崎泰成, 井上義一, 江頭玲子, 河村哲治, 佐野博幸, 上甲剛, 武村民子, 久田剛志, 福岡順也. 過敏性肺炎診療指針 2022. 過敏性肺炎診療指針 2022. 2022;
31. 倉原優. ポケット呼吸器診療2022. シーニュ・著書. 2022;
32. 倉原優. コロナ禍とアフターコロナを見据えての咳診療のあり方. 治療. 2022;104392-395.
33. 倉原優. 副鼻腔気管支症候群と上気道咳症候群の周辺. 治療. 2022;104475-478.
34. 吉田志緒美. 抗酸菌検査における培養条件の工夫の重要性. 「検査と技術」　臨床検査のピットフォール 50(4), 460-464, 2022　. 2022;50(4):460-464.
35. 松田能宣, 井上義一. 【マイナーエマージェンシー　外来診療・一人当直に強くなる!いざというときの対処法】内科的minor emergency　過換気症候群(解説). Medical Practice. 2022;39(臨増):91-92.
 
ページトップへ